tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
Calliditas Therapeutics's activity chart (see below) currently has 40 price targets and 27 ratings on display.
Analysts average stock forecasts to be materialized ratio is 35.24% with an average time for these price targets to be met of 113.5 days.
Most recent stock forecast was given by from CITI on 31-May-2024. First documented stock forecast 30-Jun-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Jul-2020
$39
$-1 (-2.50%)
$74
2 years 4 months 10 days ago
(31-May-2024)
2/6 (33.33%)
$-0.99 (-2.48%)
82
Buy Since 30-Jun-2020
$40
$55
2 years 4 months 13 days ago
(28-May-2024)
3/7 (42.86%)
$2.05 (5.40%)
469
Buy Since 30-Jun-2020
$39
$-1 (-2.50%)
2 years 4 months 13 days ago
(28-May-2024)
1/3 (33.33%)
$1.05 (2.77%)
3
Buy Since 20-Jun-2023
$39
$-1 (-2.50%)
$50
2 years 4 months 13 days ago
(28-May-2024)
1/6 (16.67%)
$1.05 (2.77%)
3
Hold Since 28-Feb-2023
$18
$-22 (-55.00%)
$18
3 years 1 months 23 days ago
(18-Aug-2023)
2/2 (100%)
$1.6 (9.76%)
21
What is CALT (Calliditas Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on CALT (Calliditas Therapeutics)?
Which analyst has the most public recommendations on CALT (Calliditas Therapeutics)?
Which analyst is the currently most bullish on CALT (Calliditas Therapeutics)?
Which analyst is the currently most reserved on CALT (Calliditas Therapeutics)?
